2cureX AB (publ) 11,10
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat test that allows the physician to identify a medical treatment that is effective for a particular cancer patient. IndiTreat establishes thousands of 3D micro-tumors that are similar to the patient's tumor and identifies the treatment that kills the patient's tumor. The company is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. 2cureX AB has clinical partnerships with Skåne University Hospital in Sweden; and University Medical Center Hamburg-Eppendorf. The company was incorporated in 2006 and is based in Copenhagen, Denmark. Læs mere
Kr. 199M Markedsværdi
Kr. 7,4M Omsætning
Bioteknologi Industri
Sverige Hjemland
2curex.com Hjemmeside
Sundhed Sektor